Evolv Technologies Holdings Toekomstige groei
Future criteriumcontroles 1/6
De verwachting is dat Evolv Technologies Holdings de winst en omzet met respectievelijk 1.5% en 15.5% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 3% per jaar.
Belangrijke informatie
1.5%
Groei van de winst
3.02%
Groei van de winst per aandeel
| Electronic winstgroei | 25.2% |
| Inkomstengroei | 15.5% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 14 May 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • May 02
EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside
Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
Narratiefupdate • Apr 18
EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
Narratiefupdate • Apr 03
EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside
Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.Narratiefupdate • Mar 20
EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside
Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.Narratiefupdate • Mar 06
EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside
Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).Narratiefupdate • Feb 20
EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026
Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.Narratiefupdate • Feb 05
EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case
Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.Narratiefupdate • Jan 22
EVLV: ARR Momentum Will Set Up A Breakout Year In 2026
Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.Narratiefupdate • Jan 08
EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook
Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.Narratiefupdate • Dec 14
EVLV: ARR Momentum Will Drive A Breakout Year In 2026
Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.Narratiefupdate • Aug 16
Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets
The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.Nieuw narratief • Jun 01
AI Screening Will Expand Public Safety Applications
Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.Analyseartikel • May 21
The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%
Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...Analyseartikel • Feb 16
After Leaping 29% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
The Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has done very well over the last month, posting an...Analyseartikel • Jan 23
Here's Why We're Not At All Concerned With Evolv Technologies Holdings' (NASDAQ:EVLV) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Analyseartikel • Dec 14
After Leaping 33% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar
Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) shareholders are no doubt pleased to see that the share price has...Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2027 | 209 | -36 | N/A | 30 | 4 |
| 12/31/2026 | 177 | -36 | N/A | 23 | 4 |
| 3/31/2026 | 160 | -36 | -10 | 18 | N/A |
| 12/31/2025 | 146 | -33 | -18 | 19 | N/A |
| 9/30/2025 | 137 | -60 | -35 | 6 | N/A |
| 6/30/2025 | 121 | -88 | -25 | 6 | N/A |
| 3/31/2025 | 114 | -44 | -47 | -17 | N/A |
| 12/31/2024 | 104 | -54 | -68 | -31 | N/A |
| 9/30/2024 | 95 | -55 | -85 | -37 | N/A |
| 6/30/2024 | 89 | -21 | -101 | -39 | N/A |
| 3/31/2024 | 83 | -91 | -102 | -23 | N/A |
| 12/31/2023 | 80 | -108 | -82 | -10 | N/A |
| 9/30/2023 | 77 | -120 | -71 | -12 | N/A |
| 6/30/2023 | 76 | -142 | -77 | -31 | N/A |
| 3/31/2023 | 65 | -101 | -80 | -49 | N/A |
| 12/31/2022 | 53 | -87 | -99 | -75 | N/A |
| 9/30/2022 | 41 | -53 | -110 | -84 | N/A |
| 6/30/2022 | 33 | -14 | -113 | -91 | N/A |
| 3/31/2022 | 28 | -11 | -97 | -74 | N/A |
| 12/31/2021 | 23 | -11 | -74 | -57 | N/A |
| 9/30/2021 | 19 | -25 | -61 | -47 | N/A |
| 6/30/2021 | 12 | -52 | -41 | -28 | N/A |
| 3/31/2021 | 8 | -35 | -36 | -27 | N/A |
| 12/31/2020 | 5 | -27 | -30 | -23 | N/A |
| 12/31/2019 | 6 | -20 | N/A | -15 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat EVLV de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat EVLV de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat EVLV de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van EVLV ( 15.5% per jaar) zal naar verwachting sneller groeien dan de markt US ( 11.7% per jaar).
Hoge groei-inkomsten: De omzet van EVLV ( 15.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van EVLV naar verwachting over 3 jaar hoog zal zijn
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/18 18:54 |
| Aandelenkoers aan het einde van de dag | 2026/05/15 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Evolv Technologies Holdings, Inc. wordt gevolgd door 5 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Jeremy Hamblin | Craig-Hallum Capital Group LLC |
| Eric Martinuzzi | Lake Street Capital Markets, LLC |
| Michael Latimore | Northland Capital Markets |